MedPath

The Effect of Aerobic Training with Vitamin D Supplementation on Cardiomyocytes Gene Expression of Type 2 Diabetic Rats.

Not Applicable
Conditions
type 2 diabetes.
Type 2 diabetes mellitus
Registration Number
IRCT20220512054832N1
Lead Sponsor
Razi University of Kermanshah
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
90
Inclusion Criteria

Age between 2 to 3 months old
To have a minimum of 300 gram of weight
To have type 2 diabetes in diabetic groups
No to have type 2 diabetes in non-diabetic obese groups
Male sex

Exclusion Criteria

Movement disabilities

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiac biomarkers. Timepoint: Before & after the intervention. Method of measurement: Elisa kit (Elabscience Company) with a sensitivity of 18,75 Pg/mL.;Vascular Endothelial Growth Factor B. Timepoint: Before & after the intervention. Method of measurement: Elisa kit (BT-LAB Company) with a sensitivity of 5.01 ng/L.;MicroRNA 1. Timepoint: Before & after intervention. Method of measurement: Polymerase chain reaction (PCR) method using The Corbett Research Rotor-Gene 6000 (QIAGEN company) and The miScript SYBR Green PCR Kit (QIAGEN company) with a sensitivity of 1.55 ng/ml.;Insulin-like growth factor 1. Timepoint: Before & after the intervention. Method of measurement: Polymerase chain reaction (PCR) method using The Corbett Research Rotor-Gene 6000 (QIAGEN company) and The Transcriptor First Strand cDNA Synthesis Kit (Roche company) with a sensitivity of 1.55 ng/ml.
Secondary Outcome Measures
NameTimeMethod
ipid profile. Timepoint: Before & after the intervention. Method of measurement: Photometry method using Pars Azmoun company kits. The sensitivity of serum level assay kit for LDL Cholesterol, HDL Cholesterol, Triglyceride, and Glucose equals 12.098 mg/dL, 22.714 mg/dL, 35.087 mg/dL, and 25.497 mg/dL, respectively.
© Copyright 2025. All Rights Reserved by MedPath